MAURIZI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 666
EU - Europa 405
AS - Asia 154
SA - Sud America 37
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.292
Nazione #
US - Stati Uniti d'America 664
IT - Italia 126
UA - Ucraina 68
SE - Svezia 41
SG - Singapore 40
CN - Cina 39
IE - Irlanda 37
RU - Federazione Russa 35
BR - Brasile 34
DE - Germania 32
DK - Danimarca 27
TR - Turchia 24
FI - Finlandia 19
HK - Hong Kong 18
CI - Costa d'Avorio 16
KR - Corea 14
IN - India 13
MA - Marocco 12
GB - Regno Unito 11
BE - Belgio 5
CA - Canada 2
FR - Francia 2
IQ - Iraq 2
AZ - Azerbaigian 1
CO - Colombia 1
DZ - Algeria 1
EC - Ecuador 1
ES - Italia 1
EU - Europa 1
JP - Giappone 1
KW - Kuwait 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
Totale 1.292
Città #
Chandler 91
Jacksonville 70
Fairfield 57
Ashburn 44
Dublin 37
New York 32
Wilmington 31
Des Moines 30
Boardman 29
Ann Arbor 28
Pianella 27
Singapore 25
Houston 23
Woodbridge 23
Seattle 21
Hong Kong 18
Abidjan 16
Beijing 16
Centro 15
Lawrence 14
Princeton 14
San Mateo 14
Turin 13
Cambridge 12
Porto 10
Milan 7
Cagliari 6
Hyderabad 6
Moscow 6
Brussels 5
Dallas 5
Helsinki 5
Pune 5
San Diego 5
Los Angeles 4
Marche 4
The Dalles 4
Council Bluffs 3
Guangzhou 3
Rome 3
Andover 2
Curitiba 2
Delhi 2
London 2
Manaus 2
Prescot 2
Shanghai 2
Terlizzi 2
Tolentino 2
Venice 2
Wuhan 2
Acton 1
Agugliano 1
Ancona 1
Anápolis 1
Araxá 1
Arcos 1
Auburn Hills 1
Baku 1
Barcarena 1
Bogotá 1
Boston 1
Brasília 1
Busano 1
Capitão Poço 1
Caxias do Sul 1
Dalian 1
Daule 1
Diamantina 1
Fermo 1
Gaiole In Chianti 1
Genova 1
Glendale 1
Gravina di Catania 1
Hounslow 1
Huskvarna 1
Ibirité 1
Icó 1
Istanbul 1
Itambé 1
Itapevi 1
Ivinhema 1
Jinan 1
Kansas City 1
Kilburn 1
Kuwait City 1
Lima 1
Macapá 1
Manila 1
Miami 1
Morada Nova de Minas 1
Mossoró 1
Mosul 1
Munich 1
Novo Hamburgo 1
Novo Triunfo 1
Nürnberg 1
Ottawa 1
Paris 1
Paulo Afonso 1
Totale 852
Nome #
Glial-like differentiation potential of human mature adipocytes 118
Azacitidine Treatment in High Risk Myelodysplastic Patients in Complete Haematological Remission Reverts Mesenchymal Stem Cells to a Normal Phenotype 114
Human bone marrow adipocytes maintain the survival and differentiation of hematopoietic stem cells 112
Plasticity of human dedifferentiated adipocytes toward endothelial cells 101
Adipocytes properties and crosstalk with immune system in obesity-related inflammation. 99
Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate 94
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes 83
Interaction between human mature adipocytes and lymphocytes induces T-cell proliferation 83
Caratterizzazione fenotipica, molecolare e proprietà immunoregolatorie delle cellule staminali mesenchimali 83
Human Mesenchymal Stem Cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion 83
DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype 81
Pleural involvement in IgG4-related disease: Case report and review of the literature 74
Identification of different adypocytes populations within human marrow microenvironment 73
TREATMENT WITH AZACITIDINE REVERSES MESENCHYMAL STEM CELLS DERIVED FROM HIGH RISK MYELODYSPLASTIC PATIENTS TO A NORMAL PHENOTYPE 73
Mesenchymal stem cells of myelodysplastic syndromes show impaired hematopoietic support function and global DNA hypermethylation status 67
Totale 1.338
Categoria #
all - tutte 6.672
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.672


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202020 0 0 0 0 0 0 0 0 0 0 0 20
2020/2021224 10 31 23 1 45 25 17 11 17 17 20 7
2021/2022125 7 28 4 4 0 5 5 10 8 19 11 24
2022/2023257 20 37 16 19 17 54 0 6 50 1 33 4
2023/2024159 20 6 9 17 25 47 2 8 0 7 8 10
2024/2025224 41 31 1 2 22 1 19 4 50 15 30 8
Totale 1.338